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Background. At present, several regions and countries are considering screening for abdominal aortic aneurysm (AAA).
However, The Chichester Aneurysms Screening Trial has reported poor long term benefit of screening for AAA. We there-
fore supplement previously published data with a preliminary analysis of the ten-year mortality from AAA, based upon
population-based data until 2002 (7 years) and incomplete hospital-based information on deaths until 2005 (10 years).
Methods and material. In 1994 we started a randomised screening trial of 12,639 64e73 year-old males; 6,306 were
controls, and 6,333 were invited to an abdominal ultrasound scan at their district hospital. Information on all deaths until
15.3.2005 was obtained from the Office of Civil Registration. Information on AAA related deaths was obtained from the
national registry of Causes of Deaths from 1.4.1994 to 31.12.2001, and supplemented with AAA deaths known to the
Danish National Patient Registry until 15.3.2005. Operations were obtained from the Danish National Vascular Registry
from 1.4.1994 to 15.3.2005.
Death certificates and medical records were reviewed by two independent assessors. The analyses were based on ‘‘inten-
tion to treat’’ from the date of randomisation.
Results. The attendance rate was 76.6% and 191 (4.0%) had an AAA. The median observation time was 9.58 years. In the
invited group 13 subjects were acutely operated on compared to 40 in the control group (Risk ratio: 0.32 (95% C.I. 0.17e
0.60, P< 0.001)), and 14 died due to AAA compared to 51 in the control group (Hazard ratio: 0.27 (95% C.I.: 0.15e0.49,
P< 0.001).
Conclusion. Over ten years, screening reduced mortality from AAA by 73%, and the frequency of emergency operations
by 68%.
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In spite of increased numbers of elective operations
for abdominal aortic aneurysms (AAA), the sex- and
age standardised mortality of ruptured AAA contin-
ued to increase.
AAA seldom causes symptoms before rupture and
when rupture occurs approximately 90% of patients
die.1e5 This is in contrast to a mortality risk of 4e7%
by elective aneurysmal resection. The presence of an
asymptomatic phase which is easily detectable by
ultrasound with a relatively low risk treatment
compared to the lethality of ruptured AAA has
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AAA. Our Viborg study has demonstrated favourable
benefits6 and cost effectiveness after five years.7 How-
ever, this is not the case in all studies.8,9 The ten year
cost effectiveness analyses from the MASS trial9 and
the Viborg Study6 were both theoretical, and were
based upon conservative assumptions: for instance,
wedidnot includepotential additional saved lives after
the observed five year period, only lives gained from18
to 60 months. Furthermore, we used the observed dif-
ference in the AAA-specific mortality rates. This is
probably an underestimation of the benefits, since the
incidence of ruptured AAA increases with age.3
On the other hand, the frequency of non-compliance
among cases with a conservatively treated AAA and
cases unfit for surgery will probably also increase
with age, and thus impair the effectiveness of screen-
ing. We therefore extended the analysis of the Viborg
trial, with population-based data for the first sevenrved.
609Ten Year Results of Screening for AAAyears, and supplementing with hospital-based data for
a further three years.
Material and Method
The study has been described in detail earlier.3,6 In
brief, in 1994 we randomised all men living in Viborg
County and born in 1921e1929. During 1995e1998 we
randomised all of those who became 65 years old that
year. The mean age at randomisation was 67.7 years
(range 64.3 to 73.8 years) (Fig. 1).
After randomisation, 6306 were controls, while
6333 were invited to an abdominal ultrasound scan
at their district hospital by a mobile screening team.
Non-responders were reinvited once. An AAA was
defined as a maximal infrarenal aortic diameter of
3 cm or more. Men with an AAA of 5 cm or more
were referred to a vascular surgeon. The remaining
AAA-patients were offered yearly follow-upexaminations, to check for any expansion. After three
to five years, 248 men with an initially ectatic aorta
were offered rescreening.10
Randomisation took place in blocks of approx. 1000
persons to avoid long delay between randomisation
and invitation to screening. Included men were ran-
domly assigned in a proportion 1:1 to be invited to
screening or to be controls. No exclusions were
made. The allocation schedule was performed by
use of Epi Info version 6.
Outcome measures
Primary outcome measures were elective and acute
operations, and deaths caused by AAA from the
time of randomisation to 15.3.2005. Operations for
AAA were identified in the national vascular registry
‘‘Karbasen’’ (www.karbase.dk). The patient records
were used to record indication, operation time,Assessed for eligibility:
Males 64-73 years old,
living in Viborg County
(N=12,639)
Excluded
(N=0)
Randomised
(N=12,639)
Randomised to screening offer
(N=6,333)
Mean age at randomisation
67.74 (SD 2.83)
Randomised to no screening
(N=6,306)
Mean age at randomisation
67.76 (SD: 2.83) 
Attended
screening
(N=4,852)
Did not attend
screening
(N=1,481)
P
Operations
lanned = 72
Emergency,
- rupture = 3 
Emergency,
+ rupture = 4 
Deaths
AAA = 10 
Total =1505 
Operations
Planned = 4
Emergency,
- rupture = 0 
Emergency,
+ rupture = 6 
Deaths
AAA = 4 
Total = 679 
Analyzed
(on intention to treat basis)
N = 6,333
Operations
Planned = 76
Emergency, - rupture =3
Emergency, + rupture = 10
Deaths
AAA = 14 
All causes =  2,184 
Analyzed
(on intention to treat basis)
N = 6,306
Operations
Planned =29 
Emergency, - rupture =9
Emergency, + rupture =31 
Deaths
AAA = 51
All causes = 2,234 
Fig. 1. Flow-chart concerning screening for abdominal aortic aneurysm.Eur J Vasc Endovasc Surg Vol 32, December 2006
610 J. S. Lindholt et al.number of preoperative blood transfusions, type of
graft, and complications. Medical and surgical com-
plications were acute myocardial infarction, cardiac
failure, severe pulmonary complications requiring
treatment, artificial ventilation for more than 48 hours,
dialysis, intensive unit stay for more than 72 hours,
stroke, arrhythmia, wound complications including
rupture, operation due to bleeding, ileus, operation
due to intestinal ischemia, thrombosis and peripheral
embolisation requiring operation.
Information on all deaths until 15.3.2005 was ob-
tained from the Office of Civil Registration. AAA as
primary or contributing cause of death was identified
in the national Registry of Causes of Death concerning
deaths taking place from April 1994 to December
2001. Causes of deaths outside hospitals were un-
known in the last period from 2002 to 2005. Conse-
quently, we obtained nation wide information on
hospital diagnoses of ruptured AAA from January
2002 until March 2005 by the National Patient Regis-
try, and AAA-related deaths after surgery as deaths
happening within 30 days after operation for AAA.
Patient records and death certificates on men with
AAA as primary or contributing cause of death and
unoperated cases of ruptured AAA who died within
the admission were reviewed by two independent
vascular surgeons. They were blinded to the random-
isation group and to each other’s evaluations, and
each assessed the deaths to be certainly, possibly or
not caused by AAA. Cases where both assessors eval-
uated the death to be certainly or possibly caused by
AAA were classified as AAA deaths. No efforts were
made to obtain agreement.6
A cost effectiveness estimate of costs per saved life
was done by using the previously reported costs for
screening and surveillance, which were prospectively
recorded during the first year of the trial. The data ob-
tained were salaries and travel reimbursement (for
doctor and nurse), stamps, envelopes, printing costs
of invitations, laptop computer, and various products
such as ultrasound gel.
To assign costs of hospitalization for surgery, the
costs calculated for planned and emergency proce-
dures in the MASS trial were used.8 The costs were
not discounted, and indirect costs for the attenders
were not included.
Statistical analyses
Risk ratios of operation for AAA and AAA-specific
deaths between the invited and the control group
were estimated by Cox regression. The analyses
were calculated on the basis of ‘‘intention to screen’’,Eur J Vasc Endovasc Surg Vol 32, December 2006from the date of randomisation to death (or operation)
or 15.03.2005.
Concerning operative characteristics, comparison
of proportions between the invited and the controls
was performed by Fisher’s exact test and odds ratios
were calculated. Comparison of means between the
invited and the controls were performed by Wilcox-
ons rank sum tests due to non-normal distributions
and unequal variances. SPSS and PEPI were used as
software for the analyses. The authors had full access
to the data and take responsibility for its integrity. All
authors have read and agree to the manuscript as
written.
Ethics
The trial was approved by the regional scientific
ethics committee and by the national data protection
authorities.
The authors have no potential conflicts of interests.
In accordance with the Clinical Trial Registration
Statement from the International Committee of Medi-
cal Journal Editors, the trial is registered at clinical tri-
als with the registration number ISRCTN65822028.
Results
As mentioned, 12,639 men were included with a mean
age of 67.7 years. The median follow up time was 9.6
years (25e75 percentiles: 6.6e10.6 years). No differ-
ences in observation length and age at inclusion
were observed between the invited group and the
control group.
The attendance rate was 76.6% (95% CI: 75.6%e
77.7%). Of the 4,852 attenders, 4816 had visible aortas,
191 (4.0%; 95% CI: 3.4%e4.6%) had an AAA at the
initial examination.
Operations
Twenty-four of the screenedmen (0.5%; 95% CI: 0.3%e
0.7%) had an AAA above 5 cm in diameter at the initial
screening scan, and were referred for surgery. During
the following years another 48 men were referred for
elective surgery due to expansion (Fig. 1). There
were 76 planned operations in the invited group
compared to 29 in the control group (Risk ratio: 2.56;
95% C.I: 1.67e3.93, P¼ 0.002) (Table 1).
Elective AAA operations among men diagnosed by
screening compared to other elective AAA operations
were characterised by significantly fewer periopera-
tive blood transfusions, shorter operation time and
an insignificant tendency to fewer complications
611Ten Year Results of Screening for AAA(29% vs 37%) e perhaps partly due to an insignifi-
cantly higher proportion of tube grafts used in the in-
vited group (58% vs 48%). However, the invited men
did not have shorter hospital stays (11.3 versus 11.4
days) (Table 2 and 3).
A total of 13 emergency procedures were per-
formed in the invited group compared to 40 in the
control group (Risk ratio: 0.32 (95% C.I. 0.17e0.60,
P< 0.001)), corresponding to 68% fewer emergency
procedures (Fig. 2). The total number of operations
was increased by 29% in the invited group corre-
sponding to four additional operations per year
among the approx. 230,000 inhabitants in Viborg
County if the screening offer became permanent.
Fig. 2 shows that the operative activity seems to
have been steady over the observation period after
an initial peak in the screening group of planned
procedures.
Mortality
Concerning planned operations, threemen diedwithin
30 days postoperatively (3.0%; 95% C.I.: 0.6e8.6%),
and a fourth died 2½ months after the operation due
to operative complications. The 30 day postoperative
mortality after emergency operations without rupture
was 33.3% (95% C.I.: 9.9e65.1%) and with rupture
58.5% (95% C.I.: 42.1e73.7%).
Table 4 and Fig. 3 shows the mortality of AAA re-
lated deaths including the late postoperative death.
There were a total of 14 AAA deaths in the invited
Table 1. Number of operations for abdominal aortic aneurysms
classified according to indication and attendance to screening
Controls Invited Non-attenders Attenders Total
Planned 29 76 4 72 105
Emergency,
 rupture
9 3 3 12
Emergency,
þ rupture
31 10 6 4 41
Total 69 89 10 79 158
Table 2. Complications and choice of graft after planned opera-
tions for asymptomatic abdominal aortic aneurysms classified
according to indication and attendance to screening
Type of complication
or graft
Controls
(N¼ 29)
Invited
(N¼ 76)
Odds ratioa P-
valueb
Wound 7 (26%) 13 (17%) 0.65 (0.21e2.08) 0.41
Surgical 2 (7%) 8 (11%) 1.59 (0.28e11.6) 0.72
Medical 4 (15%) 13 (17%) 1.29 (0.34e5.22) 0.78
All complications 10 (37%) 22 (29%) 0.77 (0.28e2.13) 0.64
Aortic tube 14 (48%) 44 (58%) 1.47 (0.57e3.79) 0.50
a Odds ratio for invited compared to controls.
b P values by Fisher’s exact test.group compared to 51 in the control group. Thus,
screening reduced deaths caused by AAA by 73%
(Hazard ratio: 0.27 (95% C.I.: 0.15e0.49, P< 0.001)
Fig. 3).
During 1994 to 2001 we recorded 48 AAA deaths
from the population-based Register of Causes of Death.
From the hospital-based information we identified 31
AAA deaths, corresponding to a reporting of 65% of
all AAA related deaths. However, in the hospital-
based data we found a similar relative risk (0.45 (95%
CI: 0.23e0.86)) as in the population-based data (0.37
(0.21e0.67)).
Fig. 4 shows the mortality from all causes. There
were 2,184 deaths in the invited group compared to
2,234 in the control group (Hazard ratio: 0.97; 95%
C.I.: 0.91e1.03).
Table 5 shows the costs per prevented death calcu-
lated to be Euro 2,301 (£1,587).
Discussion
During a 10 year period, screening for AAA in Viborg
County reduced the average frequency of emergency
operations by 68%, and mortality from AAA by 73%
by performing 29% more AAA operations.
AAA-specific and overall mortality
In the only randomised screening trial reporting long
term results, the Chichester AAA screening trial
found the benefit of screening peaked around the
fifth year and there was only a 21% lower AAA mor-
tality after 10 years.11 This is in contrast to our find-
ings. The authors suggested AAA-related deaths
among non-attenders, increasing non compliance
for surveillance and increasing frequency of contra-
indications for surgery as possible explanations.
Such problems seem not to dominate in the Viborg
trial, since Fig. 2A shows a steady activity of preven-
tive operations throughout the observation period in
the invited group - however, perhaps with a tendency
to fade out after 8e10 years. The difference between
the two studies may be age dependent; the Viborg
Study, only recruited 64e73 year old men and added
the new 65 years old men the following 4 years,
while the Chichester study recruited 65e80 year
old men.12
We could not find any sign of reduced overall mor-
tality by screening, but as in the MASS trial8 a trend
was noticed after five years, so the analysis was re-
peated after ten years, and the trend had disappeared.Eur J Vasc Endovasc Surg Vol 32, December 2006
612 J. S. Lindholt et al.Table 3. Characteristics of operations for asymptomatic abdominal aortic aneurysms classified according to offer of screening
N Mean (SD) (25) Median (75) percentiles P-value
Operation-time (min) Controls 29 170.7 (66.6) (123) 160 (210)
Invited 76 139.7 (42.5) (120) 135 (159) 0.043
Number of blood transfusions Controls 29 2.34 (3.84) (0) 1 (3)
Invited 76 0.88 (1.39) (0) 0 (2) 0.013
Admission time (days) Controls 29 11.3 (6.07) (7) 8 (14)
Invited 76 11.4 (9.09) (7) 9 (11) 0.989
P-values by Wilcoxon rank sum test.Operative complications
We have earlier reported that operations for screen-
detected AAA had less complications compared non
screen-detected AAA.13 Later, the permanent Glou-
chester screening program reported lower mortality
of operations of screen-detected AAA.14 Both findings
may be due to selection, and perhaps also to earlier
surgery in screen detected cases with consequently
more fit patients.
The present study demonstrates that the planned
operations in the screening group were shorter, re-
quired less transfusion and were more likely to em-
ploy an aortic tube. These factors are associated with
fewer complications - but the frequency of complica-
tions was not lower than in the control group. How-
ever, a trend was noticed, and it seems likely that
screening may reduce complications and periopera-
tive mortality in the long run. In the large randomised
multicentre aneurysm screening study (MASS),8 the
perioperative mortality in the screening group was
5% compared to 10% in the control group (a non-
significant difference).Eur J Vasc Endovasc Surg Vol 32, December 2006Cost effectiveness analysis
A remarkable low price per prevented death was no-
ticed. The explanation is the relatively high reduction
in AAA related mortality combined with a strong
shift in the indications of surgery. The method does
not follow the international guidelines for such stud-
ies. Among others, costs and effects of screening are
not discounted, which introduces a bias. In the
MASS trial, however, discounting actually produced
a lower cost difference between the two groups. Fur-
thermore, saved living years were not calculated
due to the lack of causes of deaths outside hospitals.
This lack of data must be expected to have increased
the costs per saved life since the number of saved
lives must be expected to be underestimated.
The British costs for surgery were chosen because it
includes additional hospital costs after discharge from
the hospital. It could be questioned whether the Brit-
ish costs of surgery can be generalised to Denmark.
The costs of planned operations compares very well
with the existing Diagnosis Related Group (DRG)
costs in Denmark at the moment, but not with the121086420
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Fig. 2. AeB. Surgical consequences of screening for abdominal aortic aneurysms concerning planned and emergency oper-
ations for abdominal aortic aneurysms.
613Ten Year Results of Screening for AAAcosts of emergency operations which seem higher
than in the MASS trial. The DRG costs are the mean
hospital costs for the treatment of a patient with a spe-
cific diagnosis. These are based on independent cost
studies from different hospitals in Denmark.
Potential bias
Our study groups had similar age distributions and av-
erage times at risk. The analysis was carried out ac-
cording to the intention to screen principle, and we
have no reason to suspect confounding. No doubt
there is an under-reporting of AAA deaths during
the last part of the follow-up period where only hospi-
tal deaths were recorded. We find, however, no reason
to believe that this under-reporting was different in the
Table 4. Deaths from abdominal aortic aneurysms classified
according to indication and attendance to screening
Controls Invited Non-attenders Attenders Total
Outside
hospital
15 2 2 17
Unoperated
at hospital
13 3 1 2 16
Planned 1 3 3 4
Emergency,
 rupture
4 4
Emergency,
þ rupture
18 6 3 3 24
Total 51 14 4 10 65
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Fig. 3. AAA specific mortality in men invited to screening or
being controls.intervention and control group, and the experience
from the first part of the study period when AAA-
related mortality from hospital-based and population-
based information could be compared, supports this
assumption.
It is possible that some deaths may have been mis-
classified as due to abdominal aortic aneurysm, as au-
topsy seldom is carried out.6 However, 53% of the
patients dying of AAA underwent surgery and 80%
died at hospital providing valid data for evaluation.
Consequently, the two vascular surgeons disagreed
on only four cases of death from hospital and autopsy
reports. The assessors were blinded to group alloca-
tion, and we conclude that classification bias seems
unlikely.
Conclusions
In all, screening increased the number of planned op-
erations 2½ times over a ten year period in Viborg
County. Despite less need for blood transfusions and
shorter operation times among elective operated cases
in the invited group compared to the control group,
the frequency of complications and the admission
time were not lower in the invited group compared
to the controls.
Screening reduced the number of emergency oper-
ations by 68%, and the net result was only 29% extra
121086420
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614 J. S. Lindholt et al.Table 5. Cost effectiveness estimation of screening for abdominal aortic aneurysms
Activitet Price per unit (Dkr) Invited group Controls
N Dkr N Dkr
Initial screening 83.75 4,852 405,601
Recall scans 83.75 845 70,768
Re-screening 83.75 248 20,770
Admissions for planned operationsa 80,420 76 6,111,920 29 2,332,180
Admissions for emergency operationsa 130,089 13 1,691,157 40 5,203,560
Total 89 8,300,021 69 7,535,740
Difference (Dkr) DKr 764,281
Difference (£) £ 70,767
Difference (Euro) Euro 102,588
Costs per saved life (DKr) DKr 20,656
Costs per saved life (£) £ 1,913
Costs per saved life (Euro) Euro 2,773
Exchange rates from the The National Danish Bank the 1st of June, 2006: 1£¼ 10.80 Dkr and 1 Euro¼ 7.45 DKr.
a Based upon results from the MASS trial (BMJ 2002;325:1135-1141).operations, and 73% lower mortality of AAA over
a ten year period in the invited group compared to
the control group. The costs per saved life were esti-
mated to be 2,773 Euros.
The study supports a substantial long term benefit
of screening for AAA.
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